SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories informs about outcome of committee meeting

23 May 2025 Evaluate
Morepen Laboratories has that the Finance Committee of the Board of Directors of the Company at its meeting held today Friday, May 23, 2025 (commenced at 9.00 am concluded at 9.55 am) has approved, availing of working capital demand loan facility, packing credit facility and post shipment facility from Qatar National Bank (‘the Bank’), to the extent of, in aggregate, Rs. 50,00,00,000/- and entered into various agreements with the Bank. The details, as required under the SEBI Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is given under as Annexure.

The above information is a part of company’s filings submitted to BSE.

Morepen Laboratories Share Price

41.27 1.15 (2.87%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×